[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Extracorporeal Membrane Oxygenation Machine Market by Product, Component, Patient Type (Neonates, Pediatrics and Adults), Modality Outlook (Veno-Venous, Veno-Arterio and Arterio-Venous), Applications, and Region - Global Forecast to 2026

November 2021 | 169 pages | ID: E8E47FB7783EN
MarketsandMarkets

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global ECMO machine market is expected to reach USD 673 million by 2026 from an estimated USD 531 million in 2021, at a CAGR of 4.9% from 2021 to 2026. An ECMO machine acts as an artificial heart and lung for a patient whose own heart or lungs cannot provide enough blood flow or get enough oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of the ECMO is to let the heat and lungs recover while the patient is supported by the ECMO machine. The major factors driving the growth of this market include the increasing geriatric population and growth in disease incidence as well as favorable government regulations, investments, and initiatives. The advantages of ECMO machines have played a key part in their adoption; their speed and accuracy, as well as quick processing times. This has pushed companies to focus on product development and innovation. However, these systems are priced at a premium, which slows their greater adoption. Other factors such as declining reimbursements, lack of infrastructure, particularly in developing and underdeveloped countries, and potential risks associated with radiation exposure are also expected to hinder the growth of this market.

“Respiratory segment accounted for the largest share of global ECMO machine market in 2020”

On the basis of applications, the ECMO machine market is segmented into respiratory, cardiac and ECPR applications. The respiratory segment is expected to dominate this market during the forecast period. Growth in this market can be attributed to the increasing prevalence of target diseases, high demand for early diagnosis and diagnostic imaging, and technological advancements in the ECMO machine market. Moreover, the rising prevalence of lung diseases like tuberculosis, thoracic malignancies, osteoporosis, fractures, and CVDs increases the demand for medical imaging for diagnosis.

“Arterio-Venous segment accounted for the largest market share of the ECMO machine market in 2020”

On the basis of modality, the ECMO machine market is segmented into veno-arterio, veno-venous and arterio-venous. The arterio-venous segment accounted for the larger market share. The advantages associated with this segment, such as effective dynamic range, better medical evaluation, are contributing to the growth of this technology segment.

“Increasing number of disorders/diseases in growing population resulting in an increase in the purchase of ECMO machines ”

On the basis of patient type, the ECMO machine market is segmented into neonates, pediatric and adults. The adult segment contributed to the largest share of global ECMO machine market in 2020. ECMO has been used for more than 40 years, and its benefits with neonates with respiratory distress are well recognized. The benefits of ECMO in adult patients with cardiac or respiratory failure are still debated, as ECMO was initially associated with low survival rates. However, recent technological advancements in ECMO circuits have led to a reduction in the rate of technical issues and complications.

“Controllers, by component, have contributed the largest share in the ECMO machine market”

Based on component, the global ECMO machine market is segmented into pumps, oxygenators, controllers, cannula and accessories. The controllers segment is expected to dominate the market during the forecast period. The large share of this segment can be attributed to the greater adoption of the systems among end users due to their lowercost compared to others.

“Portable Segment, by product type, has commanded the highest growth rate in the forecast period”

Based on product type, the ECMO machine market is segmented into Static ECMO machines and Portable ECMO machines. Portable ECMO machine segment is expected to dominate the market during the forecast period. Portable ECMO machines can be transported to any desired location and they re light in weight. These systems are especially used in a variety of imaging-set ups, including intensive care units, cardiac care units, neonatal intensive care units, operating rooms, emergency rooms, and at the patient’s beside for critically ill patients or patients with mobility challenges.

“The APAC market, by region, to register highest growth rate in the forecast period”

The ECMO Machine market is segmented into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The asia-pacific market is expected to register the highest growth in the forecast period. Growth in the ECMO machine market in the Asia Pacific is mainly driven by the growing geriatric population, particularly in Japan; increasing disposable incomes, allowing for greater affordability for advanced technologies; the rising prevalence of target diseases; and favorable government initiatives. Such factors help to drive the market for digital imaging systems in this region and draw foreign investments and partnerships. On the other hand, low hospital budgets, high equipment costs, and a lack of government investments in some countries are limiting the growth of the market in the Asia Pacific to a certain extent.

A breakdown of the primary participants referred to for this report is provided below:
  • By Company Type: Tier 1–25%, Tier 2–37%, and Tier 3– 38%
  • By Designation: C-level–34%, Director-level–35%, and Others–31%
  • By Region: North America–24%, Europe–32%, Asia Pacific–28%, Latin America–10%, and the Middle East & Africa–6%
The ECMO machine market is dominated by Fresenius Medical care AG & Co. KGaA(Germany), Getinge Group (Sweden), Microport (China). Other leading market players include Medtronic pls (US), Terumo cardiovascular Systems Corporation (Japan), Nipro Corporation (Japan), and Livanova plc (UK).

Research Coverage

This report studies the ECMO machine market based on patient type, application, product, compnent, modality outlook and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the ECMO machine market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the ECMO machine market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the ECMO machine market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
  1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKETS SCOPE
  1.3.1 MARKETS COVERED
FIGURE 1 ECMO MARKET SEGMENTATION
  1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 KEY MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
  2.1.1 SECONDARY DATA SOURCES
    2.1.1.1 Indicative list of secondary sources
  2.1.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION
2.2 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
2.3 MARKET DATA VALIDATION AND TRIANGULATION
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.4 KEY RESEARCH ASSUMPTIONS
2.5 LIMITATIONS
  2.5.1 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: ECMO MARKET
2.7 GROWTH RATE ASSUMPTIONS
2.8 COVID-19 HEALTH ASSESSMENT
2.9 COVID-19 ECONOMIC ASSESSMENT
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY (2021–2022)

3 EXECUTIVE SUMMARY

FIGURE 8 ECMO MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 9 ECMO MARKET SHARE, BY MODALITY, 2021 VS. 2026
FIGURE 10 ECMO MARKET, BY COMPONENT, 2021 VS. 2026 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE ECMO MARKET

4 PREMIUM INSIGHTS

4.1 ECMO MARKET OVERVIEW
FIGURE 12 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH
4.2 ECMO MARKET SHARE, BY REGION AND PATIENT TYPE (2020)
FIGURE 13 NORTH AMERICA DOMINATED THE ECMO MARKET IN 2020
4.3 ECMO MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 14 ECMO MACHINES SEGMENT WILL CONTINUE TO DOMINATE
THE ECMO MARKET DURING THE FORECAST PERIOD
4.4 ECMO MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 15 EMERGING MARKETS ARE ESTIMATED TO REGISTER HIGHER GROWTH RATES THAN DEVELOPED MARKETS

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 ECMO MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  5.2.1 DRIVERS
    5.2.1.1 Increasing prevalence of cardiovascular and respiratory diseases
TABLE 2 NUMBER OF DEATHS FROM CARDIOVASCULAR AND RESPIRATORY DISEASES ACROSS THE GLOBE, 1990 VS. 2019
    5.2.1.2 Growing adoption of ECMO in lung transplantation procedures
    5.2.1.3 Growth in the number of ECMO centers
TABLE 3 GLOBAL INCREASE IN THE NUMBER OF ECMO CENTERS
    5.2.1.4 Technological advancements in ECMO machines
  5.2.2 RESTRAINTS
    5.2.2.1 Complications associated with ECMO
    5.2.2.2 High cost of ECMO procedures
TABLE 4 AVERAGE COST OF ECMO IN VARIOUS COUNTRIES
  5.2.3 OPPORTUNITIES
    5.2.3.1 Increasing survival rates with ECMO
  5.2.4 CHALLENGES
    5.2.4.1 Shortage of skilled professionals
    5.2.4.2 Eligibility issues for ECMO
    5.2.4.3 Issues related to selecting the right equipment
    5.2.4.4 Risks related to the transport of ECMO patients
    5.2.4.5 Issues related to treatment decision-making
5.3 REGULATORY LANDSCAPE
TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING
THE ECMO MARKET
  5.3.1 NORTH AMERICA
    5.3.1.1 US
TABLE 6 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
    5.3.1.2 Canada
  5.3.2 EUROPE
  5.3.3 ASIA PACIFIC
    5.3.3.1 India
    5.3.3.2 Japan
TABLE 7 CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN
    5.3.3.3 China
TABLE 8 NMPA MEDICAL DEVICE CLASSIFICATION
5.4 COVID-19 IMPACT ON THE ECMO MARKET
  5.4.1 REIMBURSEMENT SCENARIO
5.5 PATENT ANALYSIS
  5.5.1 PATENTS GRANTED FOR ECMO MACHINES
TABLE 9 PATENTS GRANTED FROM 2016 TO 2021
  5.5.2 PUBLICATION TRENDS FOR PATENTS ON ECMO MACHINES
TABLE 10 FILED PATENTS, 2000–2021
TABLE 11 GRANTED PATENTS, 2010–2021
TABLE 12 PUBLISHED PATENTS, 2016–2021
5.6 VALUE CHAIN ANALYSIS
FIGURE 17 VALUE CHAIN OF THE ECMO MARKET
5.7 PRICING TREND ANALYSIS
TABLE 13 AVERAGE PRICE OF ECMO, BY COUNTRY, 2020 (USD)
5.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 14 ECMO MARKET: PORTER’S FIVE FORCES ANALYSIS
  5.8.1 THREAT OF NEW ENTRANTS
FIGURE 18 THREAT OF NEW ENTRANTS
  5.8.2 THREAT OF SUBSTITUTES
FIGURE 19 THREAT OF SUBSTITUTES
  5.8.3 BARGAINING POWER OF SUPPLIERS
FIGURE 20 BARGAINING POWER OF SUPPLIERS
  5.8.4 BARGAINING POWER OF BUYERS
FIGURE 21 BARGAINING POWER OF BUYERS
  5.8.5 INTENSITY OF COMPETITIVE RIVALRY
FIGURE 22 INTENSITY OF COMPETITIVE RIVALRY
5.9 ECOSYSTEM LANDSCAPE
FIGURE 23 ECMO MARKET: ECOSYSTEM LANDSCAPE

6 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PRODUCT

6.1 INTRODUCTION
TABLE 15 ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
6.2 ECMO MACHINES
  6.2.1 STATIC ECMO MACHINES SEGMENT TO DOMINATE
THE ECMO MACHINES MARKET
TABLE 16 ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 17 ECMO MACHINES MARKET, BY REGION, 2018–2026 (USD MILLION)
TABLE 18 ECMO MACHINES MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 19 ECMO MACHINES MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 20 ECMO MACHINES MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 21 ECMO MACHINES MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
  6.2.2 PORTABLE ECMO MACHINES
TABLE 22 PORTABLE ECMO MACHINES MARKET, BY REGION, 2018–2026 (USD MILLION)
TABLE 23 PORTABLE ECMO MACHINES MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 24 PORTABLE ECMO MACHINES MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 25 PORTABLE ECMO MACHINES MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 26 PORTABLE ECMO MACHINES MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
  6.2.3 STATIC ECMO MACHINES
TABLE 27 STATIC ECMO MACHINES MARKET, BY REGION, 2018–2026 (USD MILLION)
TABLE 28 STATIC ECMO MACHINES MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 29 STATIC ECMO MACHINES MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 30 STATIC ECMO MACHINES MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 31 STATIC ECMO MACHINES MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
6.3 SOFTWARE
  6.3.1 SOFTWARE SEGMENT TO GROW AT A STEADY CAGR DURING
THE FORECAST PERIOD
TABLE 32 ECMO SOFTWARE MARKET, BY REGION, 2018–2026 (USD MILLION)
TABLE 33 ECMO SOFTWARE MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 34 ECMO SOFTWARE MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 35 ECMO SOFTWARE MARKET, BY APPLICATION, 2018–2026 (USD MILLION)

7 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY COMPONENT

7.1 INTRODUCTION
TABLE 36 ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
7.2 PUMPS
  7.2.1 CENTRIFUGAL BLOOD PUMPS HAVE BECOME THE PUMP OF CHOICE FOR ADULT EXTRACORPOREAL LIFE SUPPORT
TABLE 37 ECMO MARKET FOR PUMPS, BY REGION, 2018–2026 (USD MILLION)
7.3 OXYGENATORS
  7.3.1 PMP OXYGENATORS HAVE SIGNIFICANTLY LESS PRIMING VOLUME
TABLE 38 ECMO MARKET FOR OXYGENATORS, BY REGION, 2018–2026 (USD MILLION)
7.4 CONTROLLERS
  7.4.1 CONTROLLERS ALLOW OPERATORS OF ECMO CIRCUITS TO ADJUST THE SETTINGS AS NEEDED
TABLE 39 ECMO MARKET FOR CONTROLLERS, BY REGION, 2018–2026 (USD MILLION)
7.5 CANNULAS
  7.5.1 THE CHOICE OF CANNULAS IS IMPORTANT IN ECMO PROCEDURES
TABLE 40 ECMO MARKET FOR CANNULAS, BY REGION, 2018–2026 (USD MILLION)
7.6 ACCESSORIES
TABLE 41 ECMO MARKET FOR ACCESSORIES, BY REGION, 2018–2026 (USD MILLION)

8 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY MODALITY

8.1 INTRODUCTION
TABLE 42 ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)
8.2 VENOARTERIAL ECMO
  8.2.1 INCREASING INCIDENCE OF HEART-LUNG FAILURE TO DRIVE
THE GROWTH OF THIS MARKET SEGMENT
TABLE 43 VENOARTERIAL ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)
8.3 VENOVENOUS ECMO
  8.3.1 VENOVENOUS ECMO IS USED WHEN ADEQUATE
HEART FUNCTION IS AVAILABLE
TABLE 44 VENOVENOUS ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)
8.4 ARTERIOVENOUS ECMO
  8.4.1 ARTERIOVENOUS ECMO MACHINES ARE SMALLER AND MORE PORTABLE
TABLE 45 ARTERIOVENOUS ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)

9 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PATIENT TYPE

9.1 INTRODUCTION
TABLE 46 COMMON INDICATIONS FOR ECMO IN NEONATES, PEDIATRIC
PATIENTS, AND ADULTS
TABLE 47 ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
9.2 NEONATES
  9.2.1 A LARGE NUMBER OF NEONATES ARE CARED FOR WITH ECMO WORLDWIDE
TABLE 48 ECMO MARKET FOR NEONATES, BY REGION, 2018–2026 (USD MILLION)
9.3 PEDIATRIC PATIENTS
  9.3.1 PEDIATRIC PATIENTS FORM A LARGE PATIENT GROUP FOR ECMO PROCEDURES
TABLE 49 ECMO MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2018–2026 (USD MILLION)
9.4 ADULTS
  9.4.1 TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE USE
OF ECMO IN ADULT PATIENTS
TABLE 50 ECMO MARKET FOR ADULTS, BY REGION, 2018–2026 (USD MILLION)

10 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION

10.1 INTRODUCTION
TABLE 51 ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
10.2 RESPIRATORY APPLICATIONS
TABLE 52 ECMO MARKET FOR RESPIRATORY APPLICATIONS, BY REGION, 2018–2026 (USD MILLION)
  10.2.1 RESPIRATORY APPLICATIONS FOR NEONATES
TABLE 53 NUMBER OF NEONATES RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS
  10.2.2 RESPIRATORY APPLICATIONS FOR PEDIATRIC PATIENTS
TABLE 54 NUMBER OF PEDIATRIC PATIENTS RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS
  10.2.3 RESPIRATORY APPLICATIONS FOR ADULTS
TABLE 55 NUMBER OF ADULTS RECEIVING ECMO SUPPORT
FOR RESPIRATORY APPLICATIONS
10.3 CARDIAC APPLICATIONS
TABLE 56 ECMO MARKET FOR CARDIAC APPLICATIONS, BY REGION, 2018–2026 (USD MILLION)
  10.3.1 CARDIAC APPLICATIONS FOR ADULTS
  10.3.2 CARDIAC APPLICATIONS FOR PEDIATRIC PATIENTS
  10.3.3 CARDIAC APPLICATIONS FOR NEONATES
10.4 EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
TABLE 57 ECMO MARKET FOR ECPR APPLICATIONS, BY REGION, 2018–2026 (USD MILLION)
  10.4.1 ECPR APPLICATIONS FOR ADULTS
  10.4.2 ECPR APPLICATIONS FOR PEDIATRIC PATIENTS
  10.4.3 ECPR APPLICATIONS FOR NEONATES

11 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY REGION

11.1 INTRODUCTION
TABLE 58 ECMO MARKET, BY REGION, 2018–2026 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 24 NORTH AMERICA: ECMO MARKET SNAPSHOT
TABLE 59 NORTH AMERICA: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)
TABLE 60 NORTH AMERICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 61 NORTH AMERICA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 62 NORTH AMERICA: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 63 NORTH AMERICA: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 64 NORTH AMERICA: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 65 NORTH AMERICA: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
  11.2.1 US
    11.2.1.1 US accounted for the largest share of the North American market
TABLE 66 US: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 67 US: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
  11.2.2 CANADA
    11.2.2.1 Implementation of the ABF model in Canadian hospitals to drive market growth
TABLE 68 CANADA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 69 CANADA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
11.3 EUROPE
TABLE 70 EUROPE: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)
TABLE 71 EUROPE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 72 EUROPE: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 73 EUROPE: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 74 EUROPE: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 75 EUROPE: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 76 EUROPE: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
  11.3.1 GERMANY
    11.3.1.1 Increasing volume of ECMO procedures to drive market
growth in Germany
TABLE 77 GERMANY: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 78 GERMANY: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
  11.3.2 FRANCE
    11.3.2.1 Rising healthcare spending to drive market growth in France
TABLE 79 FRANCE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 80 FRANCE: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
  11.3.3 UK
    11.3.3.1 Rising adoption of ECMO procedures and increasing prevalence of lifestyle diseases to drive market growth in the UK
TABLE 81 UK: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 82 UK: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
  11.3.4 ITALY
    11.3.4.1 High burden of CVDs contributing to the growth of the ECMO market in Italy
TABLE 83 ITALY: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 84 ITALY: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
  11.3.5 SPAIN
    11.3.5.1 High adoption of advanced technologies to drive market
growth in Spain
TABLE 85 SPAIN: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 86 SPAIN: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
11.4 REST OF EUROPE
TABLE 87 REST OF EUROPE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 88 REST OF EUROPE: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
11.5 ASIA PACIFIC
FIGURE 25 ASIA PACIFIC: ECMO MARKET SNAPSHOT
TABLE 89 ASIA PACIFIC: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)
TABLE 90 ASIA PACIFIC: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 91 ASIA PACIFIC: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 92 ASIA PACIFIC: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 93 ASIA PACIFIC: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 94 ASIA PACIFIC: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 95 ASIA PACIFIC: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
  11.5.1 JAPAN
    11.5.1.1 Favorable healthcare infrastructure in Japan to drive market growth
TABLE 96 JAPAN: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 97 JAPAN: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
  11.5.2 CHINA
    11.5.2.1 Rising geriatric population and increasing prevalence of
CVD to drive market growth in China
TABLE 98 CHINA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 99 CHINA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
  11.5.3 INDIA
    11.5.3.1 Growing applications and rising adoption of ECMO to drive market growth in India
TABLE 100 INDIA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 101 INDIA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
  11.5.4 AUSTRALIA
    11.5.4.1 Technological advancements to drive market growth in Australia
TABLE 102 AUSTRALIA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 103 AUSTRALIA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
  11.5.5 SOUTH KOREA
    11.5.5.1 Increasing incidence of cardiac disorders to drive market growth in South Korea
TABLE 104 SOUTH KOREA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 105 SOUTH KOREA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
  11.5.6 REST OF APAC
TABLE 106 REST OF APAC: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 107 REST OF APAC: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
11.6 LATIN AMERICA
TABLE 108 LATIN AMERICA: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION)
TABLE 109 LATIN AMERICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 110 LATIN AMERICA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 111 LATIN AMERICA: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 112 LATIN AMERICA: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 113 LATIN AMERICA: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 114 LATIN AMERICA: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)
  11.6.1 BRAZIL
    11.6.1.1 Rising adoption of ECMO as a bridge to heart and lung transplantation to drive market growth in Brazil
TABLE 115 BRAZIL: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 116 BRAZIL: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
  11.6.2 MEXICO
    11.6.2.1 High burden of CVDs in the country to drive market growth in Mexico
TABLE 117 MEXICO: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 118 MEXICO: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
  11.6.3 REST OF LATIN AMERICA
TABLE 119 REST OF LATIN AMERICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 120 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
  11.6.4 MIDDLE EAST & AFRICA
    11.6.4.1 Increasing prevalence of target diseases to drive market growth in the Middle East & Africa
TABLE 121 MIDDLE EAST & AFRICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION)
TABLE 122 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION)
TABLE 123 MIDDLE EAST & AFRICA: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION)
TABLE 124 MIDDLE EAST & AFRICA: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION)
TABLE 125 MIDDLE EAST & AFRICA: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION)
TABLE 126 MIDDLE EAST & AFRICA: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE

12.1 INTRODUCTION
FIGURE 26 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE ECMO MARKET, 2018–2021
12.2 REVENUE SHARE ANALYSIS
FIGURE 27 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET
12.3 MARKET SHARE ANALYSIS
FIGURE 28 ECMO MARKET SHARE, BY KEY PLAYER, 2020
TABLE 127 ECMO MARKET: DEGREE OF COMPETITION
12.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020)
  12.4.1 TERMINOLOGY/NOMENCLATURE
    12.4.1.1 Stars
    12.4.1.2 Emerging leaders
    12.4.1.3 Pervasive players
    12.4.1.4 Participants
FIGURE 29 ECMO MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
12.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2020)
  12.5.1 PROGRESSIVE COMPANIES
  12.5.2 RESPONSIVE COMPANIES
  12.5.3 DYNAMIC COMPANIES
  12.5.4 STARTING BLOCKS
FIGURE 30 ECMO MARKET: COMPETITIVE LEADERSHIP MAPPING FOR
SMES/START-UPS, 2020
12.6 COMPETITIVE BENCHMARKING
TABLE 128 PRODUCT FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET
TABLE 129 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS
IN THE ECMO MARKET
TABLE 130 COMPANY FOOTPRINT ANALYSIS IN THE ECMO MARKET
12.7 COMPETITIVE SCENARIO (2018–2021)
  12.7.1 NEW PRODUCT LAUNCHES & APPROVALS

13 COMPANY PROFILES

13.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
  13.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA
TABLE 131 FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS OVERVIEW
FIGURE 31 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT
TABLE 132 FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT OFFERINGS
TABLE 133 FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT LAUNCHES
  13.1.2 GETINGE GROUP
TABLE 134 GETINGE GROUP: BUSINESS OVERVIEW
FIGURE 32 GETINGE GROUP: COMPANY SNAPSHOT
TABLE 135 GETINGE GROUP: PRODUCT OFFERINGS
  13.1.3 MEDTRONIC PLC
TABLE 136 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 33 MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 137 MEDTRONIC PLC: PRODUCT OFFERINGS
  13.1.4 MICROPORT
TABLE 138 MICROPORT: BUSINESS OVERVIEW
FIGURE 34 MICROPORT: COMPANY SNAPSHOT
TABLE 139 MICROPORT: PRODUCT OFFERINGS
  13.1.5 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
FIGURE 35 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 140 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: BUSINESS OVERVIEW
TABLE 141 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: PRODUCT OFFERINGS
  13.1.6 NIPRO CORPORATION
TABLE 142 NIPRO CORPORATION: BUSINESS OVERVIEW
FIGURE 36 NIPRO CORPORATION: COMPANY SNAPSHOT
TABLE 143 NIPRO CORPORATION: PRODUCT OFFERINGS
  13.1.7 LIVANOVA PLC
TABLE 144 LIVANOVA PLC.: BUSINESS OVERVIEW
FIGURE 37 LIVANOVA PLC.: COMPANY SNAPSHOT
TABLE 145 LIVANOVA PLC: PRODUCT OFFERINGS
  13.1.8 EUROSETS S.R.L.
TABLE 146 EUROSETS S.R.L.: BUSINESS OVERVIEW
TABLE 147 EUROSETS S.R.L.: PRODUCT OFFERINGS
  13.1.9 ORIGEN BIOMEDICAL, INC.
TABLE 148 ORIGEN BIOMEDICAL, INC.: BUSINESS OVERVIEW
TABLE 149 ORIGEN BIOMEDICAL, INC.: PRODUCT OFFERINGS
  13.1.10 CYTOSORBENTS CORPORATION
TABLE 150 CYTOSORBENTS CORPORATION: BUSINESS OVERVIEW
TABLE 151 CYTOSORBENTS CORPORATION: PRODUCT OFFERINGS
  13.1.11 ABIOMED
TABLE 152 ABIOMED: BUSINESS OVERVIEW
TABLE 153 ABIOMED: PRODUCT OFFERINGS
  13.1.12 BRAILE BIOM?DICA
TABLE 154 BRAILE BIOM?DICA: BUSINESS OVERVIEW
TABLE 155 BRAILE BIOM?DICA: PRODUCT OFFERINGS
  13.1.13 SPECTRUM MEDICAL
TABLE 156 SPECTRUM MEDICAL: BUSINESS OVERVIEW
TABLE 157 SPECTRUM MEDICAL: PRODUCT OFFERINGS
  13.1.14 HAEMONETICS
TABLE 158 HAEMONETICS: BUSINESS OVERVIEW
TABLE 159 HAEMONETICS: PRODUCT OFFERINGS
  13.1.15 XENIOS AG
TABLE 160 XENIOS AG: BUSINESS OVERVIEW
TABLE 161 XENIOS AG: PRODUCT OFFERINGS
TABLE 162 XENIOS AG: PRODUCT LAUNCHES
  13.1.16 KANEKA CORPORATION
TABLE 163 KANEKA CORPORATION: BUSINESS OVERVIEW
TABLE 164 KANEKA CORPORATION: PRODUCT OFFERINGS
  13.1.17 SB-KAWASUMI LABORATORIES, INC.
TABLE 165 SB-KAWASUMI LABORATORIES, INC.: BUSINESS OVERVIEW
TABLE 166 SB-KAWASUMI LABORATORIES, INC.: PRODUCT OFFERINGS
  13.1.18 WEIGAO GROUP
TABLE 167 WEIGAO GROUP: BUSINESS OVERVIEW
TABLE 168 WEIGAO GROUP: PRODUCT OFFERINGS
  13.1.19 ZHENGYUAN TECHNOLOGY
TABLE 169 ZHENGYUAN TECHNOLOGY: BUSINESS OVERVIEW
TABLE 170 ZHENGYUAN TECHNOLOGY: PRODUCT OFFERINGS
  13.1.20 BREETHE, INC.
TABLE 171 BREETHE, INC.: BUSINESS OVERVIEW
TABLE 172 BREETHE, INC.: PRODUCT OFFERINGS
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS


More Publications